If an inhaled steroid does not help or does not relieve your symptoms enough, current guidelines from the National Heart, Lung, and Blood Institute recommend adding a long-acting bronchodilator ...

Symbicort is a combination inhaler used to control asthma and to maintain airflow in people with chronic obstructive ...

Cholinergic drugs (acetylcholine and methacholine ... Tiotropium, the first-choice long-acting bronchodilator in COPD, has been studied in severe asthmatics and in COPD patients with a history ...

There are many types of asthma inhalers. They differ in whether they're used for quick relief or long-term control, what type ...

Not for use with other long-acting β 2-agonists ... when coadministered with other inhaled asthma medications such as short-acting bronchodilators and ICS. Salmeterol Multicenter Asthma Research ...

Patients were permitted to use respiratory medications (including short-acting and long-acting beta-agonists ... Handihaler is a once-daily maintenance bronchodilator and should not be used ...

The Bronchodilator Drugs market in Central America is anticipated to witness a significant growth in revenue, with projections indicating that it will reach US$46.90m by 2024. Moreover ...

Pre-bronchodilator FEV 1 % predicted. ‡ Placebo+ refers to placebo with the addition of all regularly prescribed respiratory medications ... not receiving long-acting β-agonist or inhaled ...

The Bronchodilator Drugs market in South Korea is forecasted to achieve a revenue of US$0.37bn in 2024. It is expected to exhibit a compound annual growth rate (CAGR) of 3.99% from 2024 to 2029 ...